Key facts
- This page summarizes Ziv Nir's Form 3 filing for Turbogen Ltd. (TRBG).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 31 Aug 2026, 08:19.
Ziv Nir - 28 Aug 2026 Form 3 Insider Report for Turbogen Ltd. (TRBG)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- TRBG
- Reported as of
- 28 Aug 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Ziv Nir
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ziv Nir filed Form 3 for Turbogen Ltd. (TRBG) on 31 Aug 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002122662
Primary reporting owner
Nir Ziv
- Relationship
- Chief Operating Officer
- Address
- 22 EFAL STREET, KIRYAT ARYEH, PETAH TIKVA, ISRAEL
- Signature
- /s/ Ziv Nir
- Signature date
- 31 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TRBG
holding
Ordinary shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 130,756
- Date
- 28 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 59,257
- Exercise price
- $3.45
- Footnotes
- F2, F3
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 29,064
- Exercise price
- $1.79
- Footnotes
- F4, F5
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 28,848
- Exercise price
- $3.39
- Footnotes
- F6, F7
TRBG
holding
Derivative
Share option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Aug 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 85,000
- Exercise price
- $6.18
- Footnotes
- F8, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Represents (i) 24,988 ordinary shares, no par value per share; (ii) 10,384 restricted share units ("RSUs") granted on December 31, 2023, 56.25% of which vested and the remaining 43.75% vest in equal quarterly installments of 6.25% thereafter, of which 5,841 RSUs have vested and 4,543 remain unvested as of August 25, 2026; (iii) 10,384 RSUs granted on March 30, 2025, which vest in equal quarterly installments of 6.25% thereafter, of which 10,384 RSUs remain unvested as of August 25, 2026; and (iv) 85,000 RSUs granted on April 29, 2026, which vest in equal quarterly installments of 6.25% thereafter, of which 85,000 RSUs remain unvested as of August 25, 2026. Each RSU represents the right to receive one ordinary share.
Footnote F2
A total of 58,816 options were granted on January 26, 2023 and vested in equal quarterly installments of 6.25% beginning May 15, 2022. As of August 25, 2026, 58,816 options are fully vested and none have been exercised into ordinary shares. Number of ordinary shares issuable upon exercise of the options reflects adjustments to the Company's issued and outstanding share capital between 2021 and 2023.
Footnote F3
The options were granted with an exercise price of NIS 10.35 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $3.45 per share.
Footnote F4
A total of 28,848 options were granted on December 31, 2023 and vested in equal quarterly installments of 6.25% beginning December 30, 2023. As of August 25, 2026, 16,349 options are fully vested and none have been exercised into ordinary shares. Number of ordinary shares issuable upon exercise of the options reflects adjustments to the Company's issued and outstanding share capital between 2021 and 2023.
Footnote F5
The options were granted with an exercise price of NIS 5.38 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $1.79 per share.
Footnote F6
A total of 28,848 options were granted on March 30, 2025 and vested in equal quarterly installments of 6.25% beginning December 30, 2024. As of August 25, 2026, none of the options are fully vested and none have been exercised into ordinary shares.
Footnote F7
The options were granted with an exercise price of NIS 10.16 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $3.39 per share.
Footnote F8
A total of 85,000 options were granted on April 29, 2026 and vest in equal quarterly installments of 6.25% beginning April 29, 2027. As of August 25, 2026, none of options are fully vested and none have been exercised into ordinary shares.
Footnote F9
The options were granted with an exercise price of NIS 18.5 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $6.18 per share.